Last reviewed · How we verify

NCT02835937

Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status

Completed NA Last updated 15 February 2019
What this trial tests

NA trial testing No-Transfuse in Red Blood Cell Transfusions in 20 participants. Completed in 10 November 2017.

Timeline
1 September 2016
Primary endpoint
10 November 2017
10 November 2017

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment20
Start date1 September 2016
Primary completion10 November 2017
Estimated completion10 November 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Red Blood Cell Transfusions or Anemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Do ambulatory RBC transfusions improve home functional status?

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
    Radford M, Estcourt LJ, Sirotich E, Pitre T, et al · · 2024 · cited 8× · PMID 38780066 · DOI 10.1002/14651858.cd011305.pub3
  2. Measuring the impact of ambulatory red blood cell transfusion on home functional status: study protocol for a pilot randomized controlled trial.
    Murphree DH, Kinard TN, Khera N, Storlie CB, et al · · 2017 · cited 4× · PMID 28359342 · DOI 10.1186/s13063-017-1873-z

Verify or expand the search:

Other recruiting trials for Red Blood Cell Transfusions

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02835937.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing